Skip Nav Destination
Close Modal
Update search
Filter
All
- All
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISBN
- EISBN
- ISSN
- EISSN
- Issue
- Volume
- References
Filter
All
- All
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISBN
- EISBN
- ISSN
- EISSN
- Issue
- Volume
- References
Filter
All
- All
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISBN
- EISBN
- ISSN
- EISSN
- Issue
- Volume
- References
Filter
All
- All
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISBN
- EISBN
- ISSN
- EISSN
- Issue
- Volume
- References
Filter
All
- All
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISBN
- EISBN
- ISSN
- EISSN
- Issue
- Volume
- References
Filter
All
- All
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISBN
- EISBN
- ISSN
- EISSN
- Issue
- Volume
- References
NARROW
Format
Subjects
Journal
Article Type
Issue Section
Date
Availability
1-18 of 18
Keywords: Heart failure
Close
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Sort by
Journal Articles
Journal:
Heart Drug
Heart Drug (2005) 5 (4): 220–229.
Published Online: 22 December 2005
..., instructions or products referred to in the content or advertisements. 2005 Nicorandil Angina pectoris Ischemic heart disease Heart failure Ischemic preconditioning Review Heart Drug 2005;5:220 229 DOI: 10.1159/000089603 Received: April 21, 2005 Accepted after revision: July 25, 2005 Published...
Journal Articles
Journal:
Heart Drug
Heart Drug (2005) 5 (2): 89–99.
Published Online: 11 March 2005
...Pamela N. Peterson; Frederick A. Masoudi Heart failure is predominantly a condition of the elderly and is associated with substantial mortality, morbidity and functional limitation. In clinical trials of patients with left ventricular systolic dysfunction (LVSD), angiotensin-converting enzyme (ACE...
Journal Articles
Journal:
Heart Drug
Heart Drug (2005) 5 (2): 81–88.
Published Online: 11 March 2005
...Thomas L. Lenz; Daniel E. Hilleman Background: Approximately 5 million Americans have heart failure, with 550,000 new cases diagnosed each year. In the United States, approximately 500 million USD is spent annually on drug treatment for heart failure alone. Cost-effective treatment that prevents...
Journal Articles
Victor L. Serebruany, Christopher J. Davis, Andrew F. Meister, Dan Atar, David J. Whellan, Christopher M. O’Connor
Journal:
Heart Drug
Heart Drug (2001) 1 (2): 110–124.
Published Online: 17 November 2004
...Victor L. Serebruany; Christopher J. Davis; Andrew F. Meister; Dan Atar; David J. Whellan; Christopher M. O’Connor Knowledge of the pathogenesis of congestive heart failure (CHF) has improved greatly in recent years. Nevertheless, this disease still causes high morbidity and mortality...
Journal Articles
Journal:
Heart Drug
Heart Drug (2004) 4 (3): 145–150.
Published Online: 13 August 2004
..., losartan has proven slightly more efficient than atenolol to prevent cardiovascular complications, overall mortality was however identical. In heart failure, AIIA should only be considered in ACE inhibitor-intolerant patients. Both ACE inhibitors and AIIA have proven efficient in diabetic microalbuminuria...
Journal Articles
Journal:
Heart Drug
Heart Drug (2003) 3 (3): 147–152.
Published Online: 21 November 2003
...Massimo F. Piepoli; Giovanni Q. Villani; Alessandro Capucci In patients with advanced chronic heart failure, characterised by prolonged QRS duration and impaired cardiac contractility, decreasing dyssynchrony by biventricular pacing seems to improve exercise tolerance (6-min walk distance...
Journal Articles
Journal:
Heart Drug
Heart Drug (2003) 3 (3): 164–170.
Published Online: 21 November 2003
... Antiarrhythmic drugs Anticoagulation Atrial fibrillation Heart failure Review Heart Drug 2003;3:164 170 DOI: 10.1159/000072741 Received: March 12, 2003 Accepted after revision: May 12, 2003 Atrial Fibrillation: Rhythm or Rate Control? Maurizio Landolina Gaetano M. De Ferrari Francesco Cantù Barbara...
Journal Articles
Journal:
Heart Drug
Heart Drug (2003) 3 (3): 141–146.
Published Online: 21 November 2003
... importance. Objectives: We sought to evaluate the performance of a new N-terminal pro-brain natriuretic peptide (NT-proBNP) analysis in diagnosing LVSD in primary care patients with a provisional diagnosis of heart failure referred for echocardiography. Methods: Serum levels of NT-proBNP were measured...
Journal Articles
Journal:
Heart Drug
Heart Drug (2003) 3 (3): 153–158.
Published Online: 21 November 2003
... are complex and include direct effects on the vasculature, systemic hemodynamic effects and effects on the myocardium, including actions on contractility, myocyte hypertrophy and extracellular matrix deposition. Plasma levels of urotensin have been found to be elevated in patients with chronic heart failure...
Journal Articles
Journal:
Heart Drug
Heart Drug (2003) 3 (2): 107–112.
Published Online: 20 August 2003
... in this homeostatic process. Vasopressin, also known as antidiuretic hormone, is secreted from the posterior pituitary in response to signals generated from hypothalamic osmoreceptors when increased plasma osmolality is detected. Neurohormonal activation in congestive heart failure results in a nonosmotic release...
Journal Articles
Journal:
Heart Drug
Heart Drug (2002) 2 (6): 286–294.
Published Online: 09 April 2003
... of cilazapril and valsartan to cilazapril as monotherapy in 46 patients with advanced heart failure of ischaemic aetiology. Methods: The design of the study is double blind, double dummy, with parallel groups. Diuretics and β-blockers were used as a basal therapy, and many patients were treated with digoxin...
Journal Articles
Journal:
Heart Drug
Heart Drug (2002) 2 (6): 295–302.
Published Online: 09 April 2003
...Michael Sosin; Gurbir Bhatia; Gregory Y.H. Lip Congestive heart failure (CHF) is increasing in prevalence in Western society and is associated with considerable morbidity and mortality, including a high risk of venous thromboembolism and stroke. In addition, up to 50% of CHF sufferers die of sudden...
Journal Articles
Journal:
Heart Drug
Heart Drug (2002) 2 (5): 211–220.
Published Online: 21 January 2003
...U. Alehagen; H. Eriksson; E. Nylander; U. Dahlström Background: Heart failure (HF) is a challenge to diagnose and treat according to guidelines. Few studies have been performed in elderly subjects with symptoms that might be associated with HF in primary health care. Objective: To study elderly...
Journal Articles
Journal:
Heart Drug
Heart Drug (2002) 2 (4): 164–166.
Published Online: 08 November 2002
...Mihai Gheorghiade; Wendy A. Gattis; Mary Ann Lukas; Christopher M. O’Connor β-Blockers for the treatment of heart failure are underprescribed in the United States despite the availability of extensive data and the current guidelines that support their use. The ongoing Initiation Management...
Journal Articles
Journal:
Heart Drug
Heart Drug (2002) 2 (3): 135–141.
Published Online: 25 July 2002
...Otto Mølby Henriksen; Niels Gadsbøll It has been suggested that drugs for the treatment of heart failure which lower heart rate (HR) have a beneficial effect on mortality, whereas the reverse is true for drugs that increase HR. The objective of this review was to examine the relationship between...
Journal Articles
Journal:
Heart Drug
Heart Drug (2002) 2 (1): 39–46.
Published Online: 02 April 2002
...Mary R. Burger; Andrew J. Burger Heart failure is characterized by sodium and fluid retention, sympathetic overactivity, parasympathetic withdrawal, vasoconstrictor activation and cytokine elevation. Current treatment for acute heart failure consists of vasodilators, diuretics and inotropes...
Journal Articles
Journal:
Heart Drug
Heart Drug (2001) 1 (4): 236–240.
Published Online: 31 October 2001
... vasodilator. Similarly, certain studies albeit small ones have shown that natriuretic agents which promote diuresis by augmenting the body’s defence against the abnormal neurohormonal milieu evident in heart failure might have a better effect on long-term prognosis than the symptomatically much more effective...
Journal Articles
Søren Boesgaard, Nicolai Gruhn, Michael C.J. Wanscher, Kaare M. Sander, Svend A. Mortensen, Jan Aldershvile
Journal:
Heart Drug
Heart Drug (2001) 1 (3): 176–181.
Published Online: 31 July 2001
...Søren Boesgaard; Nicolai Gruhn; Michael C.J. Wanscher; Kaare M. Sander; Svend A. Mortensen; Jan Aldershvile Even though treatments of both acute myocardial infarction (MI) and congestive heart failure have improved substantially, the management of cardiogenic shock following acute MI remains...